Mission Bio Launches Tapestri Triomics for Single-Cell Analysis
SOUTH SAN FRANCISCO, Calif. — September 16, 2026 Mission Bio announced the launch of Tapestri® Triomics, a new expansion...
drug development
Advertisement
Waters Launches BD FACSDiscover A7 Spectral Flow Cytometer
Milford, Massachusetts, U.S., September 14, 2026 Waters Corporation has announced the global commercial launch of the BD FACSDiscover™ A7...
Corbus Advances CRB-913 Toward Phase 2 in Obesity
NORWOOD, Mass. — September 14, 2026 Corbus Pharmaceuticals Holdings, Inc. announced positive topline results from its CANYON-1 Phase 1b...
Telomir Advances Telomir-Zn in Human and Canine Osteosarcoma
MIAMI, Fla. — September 14, 2026 Telomir Pharmaceuticals, Inc. announced new research conducted with The Ohio State University College...
Santa Ana Bio Advances SAB01 Into Phase 1
ALAMEDA, Calif. — September 14, 2026 Santa Ana Bio announced that the first cohort has been dosed in the...
Advertisements
AbelZeta’s C-CAR168 Receives FDA IND Clearance
San Diego, California, U.S., September 14, 2026 AbelZeta Therapeutics has announced that the U.S. Food and Drug Administration (FDA)...
Clearmind Medicine Advances CMND-100 Into AUD Clinical Trial
VANCOUVER, Canada — September 11, 2026 Clearmind Medicine Inc. announced that the first patients with Alcohol Use Disorder (AUD)...
Quantum BioPharma Advances Lucid-MS Toward Phase 2 in MS
NEW YORK — September 11, 2026 Quantum BioPharma Ltd. announced that the U.S. Food and Drug Administration has cleared...
GSK’s Jideytro Shows 94% Response in ROS1 Lung Cancer
London, United Kingdom, September 13, 2026 GSK has announced positive registrational data from the Phase I/II ARROS-1 trial supporting...
Takeda Zasocitinib Gets FDA Priority Review for Psoriasis
Osaka, Japan & Cambridge, Massachusetts, U.S., September 14, 2026 Takeda has announced that the U.S. Food and Drug Administration...
Advertisement
